|
Cellectar closes secondary stock offering
Madison.com Cellectar Biosciences closed its secondary stock offering on Wednesday with gross proceeds of $13.5 million from the sale of 4.7 million shares of common stock and 5 million warrants to buy additional stock. Net proceeds were $12.4 million, the company … |
